» Articles » PMID: 17940114

Pendred Syndrome in Two Galician Families: Insights into Clinical Phenotypes Through Cellular, Genetic, and Molecular Studies

Abstract

Context: We studied two families from Galicia (northwest Spain) with Pendred syndrome (PS) and unusual thyroid phenotypes. In family A, the proposita had a large goiter and hypothyroxinemia but normal TSH and free T3 (FT3). In family B, some affected members showed deafness but not goiter.

Objective: Our objective was to identify the mutations causing PS and molecular mechanisms underlying the thyroid phenotypes.

Interventions: Interventions included extraction of DNA and of thyroid tissue.

Patients: Propositi and 10 members of the two families participated in the study.

Main Outcome Measures: Main outcome measures included SLC26A4 gene analysis, deiodinase activities in thyroid tissue, and c.416-1G-->A effects on SLC26A4 splicing. In addition, a primary PS thyrocyte culture, T-PS2, was obtained from propositus B and compared with another culture of normal human thyrocytes, NT, by Western blotting, confocal microscopy, and iodine uptake kinetics.

Results: Proposita A was heterozygous for c.578C-->T and c.279delT, presented with goiter, and had normal TSH and FT3 but low FT4 attributable to high type 1 and type 2 iodothyronine deiodinase activities in the goiter. Propositus B bore c.279delT and a novel mutation c.416-1G-->A; some deaf relatives were homozygous for c.416-1G-->A but did not present goiter. The c.279delT mutation was associated with identical haplotype in the two families. T-PS2 showed truncated pendrin retained intracellularly and high iodine uptake with low efflux leading to iodine retention.

Conclusions: c.279delT is a founder mutation in Galicia. Proposita A adapted to poor organification by increasing deiodinase activities in the goiter, avoiding hypothyroidism. Lack of goiter in subjects homozygous for c.416-1G-->A was due to incomplete penetrance allowing synthesis of some wild-type pendrin. Intracellular iodine retention, as seen in T-PS2, could play a role in thyroid alterations in PS.

Citing Articles

Hearing loss with two pathogenic variants and positive thyroid autoantibody: A case report.

Miura A, Nakagawa T, Sogi C, Shima H, Adachi M, Honkura Y Clin Pediatr Endocrinol. 2024; 33(4):219-223.

PMID: 39359669 PMC: 11442696. DOI: 10.1297/cpe.2023-0084.


Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process.

Vazquez-Roman V, Cameselle-Teijeiro J, Fernandez-Santos J, Rios-Moreno M, Loidi L, Ortiz T Endocr Pathol. 2022; 33(4):484-493.

PMID: 36242759 PMC: 9712347. DOI: 10.1007/s12022-022-09732-2.


Molecular Features of SLC26A4 Common Variant p.L117F.

Matulevicius A, Bernardinelli E, Brownstein Z, Roesch S, Avraham K, Dossena S J Clin Med. 2022; 11(19).

PMID: 36233414 PMC: 9570580. DOI: 10.3390/jcm11195549.


Transcriptomic Analyses of Inner Ear Sensory Epithelia in Zebrafish.

Yao Q, Wang L, Mittal R, Yan D, Richmond M, Denyer S Anat Rec (Hoboken). 2019; 303(3):527-543.

PMID: 31883312 PMC: 8108486. DOI: 10.1002/ar.24331.


Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.

Kanavy D, McNulty S, Jairath M, Brnich S, Bizon C, Powell B Genome Med. 2019; 11(1):77.

PMID: 31783775 PMC: 6884856. DOI: 10.1186/s13073-019-0683-1.


References
1.
Gonzalez Trevino O, Karamanoglu Arseven O, Ceballos C, Vives V, Ramirez R, Gomez V . Clinical and molecular analysis of three Mexican families with Pendred's syndrome. Eur J Endocrinol. 2001; 144(6):585-93. DOI: 10.1530/eje.0.1440585. View

2.
Obregon M, Ruiz de Ona C, Calvo R, Escobar del Rey F, Morreale de Escobar G . Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology. 1991; 129(5):2663-73. DOI: 10.1210/endo-129-5-2663. View

3.
Lopez-Bigas N, Melchionda S, de Cid R, Grifa A, Zelante L, Govea N . Erratum: Identification of five new mutations of PDS/SLC26A4 in Mediterranean families with hearing impairment. Hum Mutat. 2002; 20(1):77-8. DOI: 10.1002/humu.9043. View

4.
Everett L, Glaser B, Beck J, Idol J, Buchs A, Heyman M . Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997; 17(4):411-22. DOI: 10.1038/ng1297-411. View

5.
Friedman T, Griffith A . Human nonsyndromic sensorineural deafness. Annu Rev Genomics Hum Genet. 2003; 4:341-402. DOI: 10.1146/annurev.genom.4.070802.110347. View